MICHAEL WOUDENBERG - 27 May 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Chief Operating Officer
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg
Issuer symbol
INM
Transactions as of
27 May 2024
Net transactions value
$0
Form type
4
Filing time
28 May 2024, 16:27:14 UTC
Previous filing
26 Dec 2023
Next filing
23 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -394 -0.52% $0.000000 75,100 27 May 2024 Common shares 394 $263.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00